Citigroup’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.87M Buy
85,011
+45,842
+117% +$4.79M ﹤0.01% 1069
2025
Q1
$4.57M Sell
39,169
-3,792
-9% -$442K ﹤0.01% 1468
2024
Q4
$3.63M Buy
42,961
+7,342
+21% +$621K ﹤0.01% 1676
2024
Q3
$3.2M Buy
35,619
+18,821
+112% +$1.69M ﹤0.01% 1678
2024
Q2
$1.35M Sell
16,798
-78,274
-82% -$6.3M ﹤0.01% 2035
2024
Q1
$7.59M Sell
95,072
-6,655
-7% -$531K 0.01% 1037
2023
Q4
$8.1M Sell
101,727
-935
-0.9% -$74.4K 0.01% 921
2023
Q3
$7.18M Buy
102,662
+39,904
+64% +$2.79M 0.01% 911
2023
Q2
$4.51M Buy
62,758
+14,436
+30% +$1.04M ﹤0.01% 1147
2023
Q1
$2.98M Buy
48,322
+7,724
+19% +$476K ﹤0.01% 1332
2022
Q4
$3.13M Sell
40,598
-7,807
-16% -$602K ﹤0.01% 1270
2022
Q3
$2.16M Sell
48,405
-11,341
-19% -$506K ﹤0.01% 1549
2022
Q2
$2.29M Buy
59,746
+50,842
+571% +$1.95M ﹤0.01% 1497
2022
Q1
$370K Sell
8,904
-3,380
-28% -$140K ﹤0.01% 3041
2021
Q4
$464K Sell
12,284
-34,587
-74% -$1.31M ﹤0.01% 3114
2021
Q3
$1.55M Buy
46,871
+39,289
+518% +$1.3M ﹤0.01% 2083
2021
Q2
$512K Buy
7,582
+1,608
+27% +$109K ﹤0.01% 3054
2021
Q1
$338K Sell
5,974
-7,297
-55% -$413K ﹤0.01% 3080
2020
Q4
$1.08M Buy
13,271
+2,024
+18% +$165K ﹤0.01% 2117
2020
Q3
$801K Sell
11,247
-192,320
-94% -$13.7M ﹤0.01% 2003
2020
Q2
$16.8M Buy
203,567
+191,673
+1,612% +$15.8M 0.01% 568
2020
Q1
$700K Buy
11,894
+3,547
+42% +$209K ﹤0.01% 2064
2019
Q4
$862K Buy
8,347
+5,838
+233% +$603K ﹤0.01% 2298
2019
Q3
$51K Buy
2,509
+2,487
+11,305% +$50.6K ﹤0.01% 3759
2019
Q2
$1K Sell
22
-18,590
-100% -$845K ﹤0.01% 5026
2019
Q1
$265K Buy
+18,612
New +$265K ﹤0.01% 2940
2017
Q3
Sell
-1
Closed 4698
2017
Q2
$0 Sell
1
-38
-97% ﹤0.01% 4868
2017
Q1
$0 Sell
39
-3,406
-99% ﹤0.01% 4797
2016
Q4
$23K Buy
3,445
+2,533
+278% +$16.9K ﹤0.01% 4345
2016
Q3
$7K Sell
912
-209
-19% -$1.6K ﹤0.01% 4539
2016
Q2
$8K Buy
+1,121
New +$8K ﹤0.01% 4576